These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11714983)

  • 1. Elevated expression of c-myc in lymphoblastoid cells does not support an Epstein-Barr virus latency III-to-I switch.
    Pajic A; Polack A; Staege MS; Spitkovsky D; Baier B; Bornkamm GW; Laux G
    J Gen Virol; 2001 Dec; 82(Pt 12):3051-3055. PubMed ID: 11714983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.
    Faumont N; Durand-Panteix S; Schlee M; Grömminger S; Schuhmacher M; Hölzel M; Laux G; Mailhammer R; Rosenwald A; Staudt LM; Bornkamm GW; Feuillard J
    J Virol; 2009 May; 83(10):5014-27. PubMed ID: 19264782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
    Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
    Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS
    Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
    Kelly G; Bell A; Rickinson A
    Nat Med; 2002 Oct; 8(10):1098-104. PubMed ID: 12219084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.
    Bristol JA; Nelson SE; Ohashi M; Casco A; Hayes M; Ranheim EA; Pawelski AS; Singh DR; Hodson DJ; Johannsen EC; Kenney SC
    PLoS Pathog; 2024 Apr; 20(4):e1012132. PubMed ID: 38620028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
    Price AM; Messinger JE; Luftig MA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.
    Polack A; Hörtnagel K; Pajic A; Christoph B; Baier B; Falk M; Mautner J; Geltinger C; Bornkamm GW; Kempkes B
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10411-6. PubMed ID: 8816814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LCR of EBV makes Burkitt's lymphoma endemic.
    Niller HH; Salamon D; Banati F; Schwarzmann F; Wolf H; Minarovits J
    Trends Microbiol; 2004 Nov; 12(11):495-9. PubMed ID: 15488390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
    Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
    J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells.
    Pajic A; Staege MS; Dudziak D; Schuhmacher M; Spitkovsky D; Eissner G; Brielmeier M; Polack A; Bornkamm GW
    Int J Cancer; 2001 Sep; 93(6):810-6. PubMed ID: 11519042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.
    Schlee M; Krug T; Gires O; Zeidler R; Hammerschmidt W; Mailhammer R; Laux G; Sauer G; Lovric J; Bornkamm GW
    J Virol; 2004 Apr; 78(8):3941-52. PubMed ID: 15047810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.
    Staege MS; Lee SP; Frisan T; Mautner J; Scholz S; Pajic A; Rickinson AB; Masucci MG; Polack A; Bornkamm GW
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4550-5. PubMed ID: 11917131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature.
    Kelly GL; Stylianou J; Rasaiyaah J; Wei W; Thomas W; Croom-Carter D; Kohler C; Spang R; Woodman C; Kellam P; Rickinson AB; Bell AI
    J Virol; 2013 Mar; 87(5):2882-94. PubMed ID: 23269792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
    Hutchings IA; Tierney RJ; Kelly GL; Stylianou J; Rickinson AB; Bell AI
    J Virol; 2006 Nov; 80(21):10700-11. PubMed ID: 16920819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1.
    Zhang L; Pagano JS
    J Virol; 2000 Feb; 74(3):1061-8. PubMed ID: 10627515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma.
    Ruf IK; Rhyne PW; Yang H; Borza CM; Hutt-Fletcher LM; Cleveland JL; Sample JT
    Curr Top Microbiol Immunol; 2001; 258():153-60. PubMed ID: 11443860
    [No Abstract]   [Full Text] [Related]  

  • 19. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage.
    Kerr BM; Lear AL; Rowe M; Croom-Carter D; Young LS; Rookes SM; Gallimore PH; Rickinson AB
    Virology; 1992 Mar; 187(1):189-201. PubMed ID: 1310556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
    Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
    Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.